Romiplostim - an emergency treatment of intracranial haemorrhage in the course of severe primary immune thrombocytopaenia

We present a case of a 16-year-old girl with newly diagnosed/persistent immune thrombocytopaenia (ITP) with a complication of intracranial haemorrhage. She did not respond adequately to first-line treatment, i.e. intravenous immunoglobulin infusions, glucocorticosteroids, and transfusion of platelet...

Full description

Saved in:
Bibliographic Details
Main Authors: Paweł Łaguna (Author), Aleksandra Sikorska (Author), Joanna Kulik (Author), Michał Matysiak (Author)
Format: Book
Published: Termedia Publishing House, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We present a case of a 16-year-old girl with newly diagnosed/persistent immune thrombocytopaenia (ITP) with a complication of intracranial haemorrhage. She did not respond adequately to first-line treatment, i.e. intravenous immunoglobulin infusions, glucocorticosteroids, and transfusion of platelets, and developed numerous bleeding complications. During the treatment she developed bleeding into the central nervous system, which is a rare and devastating complication of ITP. In such cases, the available data in the literature suggest a potential role of the thrombopoietin receptor agonist as a life-saving emergency treatment for severe, newly diagnosed immune thrombocytopaenia. The prognosis of our patient's survival and neurological status was completely dependent on this treatment. After obtaining consent from the appropriate bioethics committee, romiplostim was administered to the patient, with a good response and without side effects.
Item Description:0031-3939
2300-8660
10.5114/polp.2022.122870